Startups
Your DNA undergoes tens of thousands of incidences of damage every day from normal biological functions as well as environmental factors. This type of damage can accumulate to cause aging, degeneration, and even mutations. These damages and mutations are irreversible and could prevent us from using our own biology and cells to repair or regenerate our bodies in the future.
Silene Biotech is bringing stem cell technology to consumers. We offer low-cost adult cell preservation and stem cell generation for use in future regenerative therapies and personalized medicine. We actively partner with academic institutions, biotech and pharma to accelerate the development of diagnostic and cures while providing clinical-grade cell preservation to our consumers.
Silene Biotech is bringing stem cell technology to consumers. We offer low-cost adult cell preservation and stem cell generation for use in future regenerative therapies and personalized medicine. We actively partner with academic institutions, biotech and pharma to accelerate the development of diagnostic and cures while providing clinical-grade cell preservation to our consumers.
Overview
Location
United States, Washington, Seattle
Phone
+1 206-900-1181
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Techstars | techstars.com |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 25, 2019 | Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal | Silene CEO Dr. Alex Jiao. (NanoSurface Photo) NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance of stem cells in drug development. With the acquisition, NanoSurface i... |
| Feb 15, 2017 | This startup preserves your cells for the future, to capitalize on medical breakthroughs yet to come | Silene Biotech co-founders Alex Jiao, left, and Jenna Strully. (Silene Biotech Photo) Silene Biotech wants to help you grow a new heart or liver, in case those organs fail when you get older. The ambitious Seattle startup — founded two year... |
| Jan 26, 2017 | Techstars Picks 9 Startups For Seattle, Complementing Local Strengths | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Techstars has named nine startup companies for its 2017 Seattle accelerator class, each with a focus that complements one of the region’s core or emerging technology strengths... |
| Jan 26, 2017 | Here are the 9 startups in Techstars Seattle’s newest class | Here comes another round of Techstars Seattle startups. The 3-month accelerator announced its 2017 cohort on Thursday. The group, which marks the eighth overall for Techstars Seattle, includes nine companies working in various industries ra... |
Reviews 0
FAQ about Silene Biotech
Who has invested in Silene Biotech?
Parsers VC lists 2 investors of Silene Biotech, among them Techstars.
What has the press written about Silene Biotech?
Parsers VC has collected 5 articles mentioning Silene Biotech, among them “Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal” (Sep 25, 2019) and “This startup preserves your cells for the future, to capitalize on medical breakthroughs yet to come” (Feb 15, 2017).
Is Silene Biotech still active?
Yes, Silene Biotech is active; its latest activity on Parsers VC dates from Feb 17, 2022.